Obstet Gynecol Sci.  2020 Apr;63(3):305-314. 10.5468/ogs.2020.63.3.305.

Randomized controlled trial for improved recovery of the pelvic floor after vaginal delivery with a specially formulated postpartum supplement

• Takacs P
• Kozma B
• Lampé R
• Sipos A
• Poka R

• KMID: 2500420
• DOI: http://doi.org/10.5468/ogs.2020.63.3.305

Abstract

Objective
To improve pelvic floor recovery after vaginal delivery with daily supplementation of a specially formulated postpartum recovery supplement.
Methods
Within 48 hours of vaginal delivery, primipara women were randomized in a 1:1 ratio to receive daily oral supplementation for 6 weeks with either a combination of regular prenatal vitamin (PNV), leucine (4 g/day), zinc (30 mg/day) and omega-3 fatty acid (900 mg/day) (treatment group), or only a PNV daily (control group). Co-primary outcomes were vaginal squeeze pressure as measured by perineometer and levator muscle injury as measured by transperineal 3-dimensional tomographic ultrasound at 6 weeks postpartum.
Results
Twenty-six women in the control group and 27 in the treatment group completed the trial. Weak pelvic floor muscle strength was significantly less frequent in the treatment group compared to the control group at 6 weeks after delivery (28% vs. 58%, P=0.03). Both right and left-sided levator-urethra gap was significantly larger in the control group compared to the treatment group indicating more levator injury being present in the control group at 6 weeks after delivery. Anterior vaginal wall prolapse at or beyond the hymenal ring was significantly more common in the control group compared to the treatment group (19% vs. 0%, P=0.02). Significantly more women reported bothersome bulge symptoms in the control group compared to the treatment group at 6 weeks postpartum (19% vs. 0%, P=0.02).
Conclusion
Postpartum women who received a specially formulated postpartum recovery supplement had improved recovery of the pelvic floor after vaginal delivery.

Keyword

Postpartum; Pelvic floor; Omega-3 fatty acids; Zinc; Leucine

Figure

• 

  Fig. 1 Flow of participants through the randomized clinical trial. Participants were allocated to treatment or control groups.

Reference

1. Rørtveit G, Hannestad YS. Association between mode of delivery and pelvic floor dysfunction. Tidsskr Nor Laegeforen. 2014; 134:1848–1852. PMID: 25314985.

2. Chaliha C. Postpartum pelvic floor trauma. Curr Opin Obstet Gynecol. 2009; 21:474–479. PMID: 19855276.

3. Özdemır ÖÇ, Bakar Y, Özengın N, Duran B. The effect of parity on pelvic floor muscle strength and quality of life in women with urinary incontinence: a cross sectional study. J Phys Ther Sci. 2015; 27:2133–2137. PMID: 26311939.

4. Hilde G, Stær-Jensen J, Siafarikas F, Engh ME, Brækken IH, Bø K. Impact of childbirth and mode of delivery on vaginal resting pressure and on pelvic floor muscle strength and endurance. Am J Obstet Gynecol. 2013; 208:50.e1–50.e7. PMID: 23103345.

5. Dietz HP, Simpson JM. Does delayed child-bearing increase the risk of levator injury in labour? Aust N Z J Obstet Gynaecol. 2007; 47:491–495. PMID: 17991115.

6. Dietz HP. Ultrasound in the assessment of pelvic organ prolapse. Best Pract Res Clin Obstet Gynaecol. 2019; 54:12–30. PMID: 30082146.

7. Atan IK, Lin S, Dietz HP, Herbison P, Wilson PD. ProLong Study Group. Levator avulsion is associated with pelvic organ prolapse 23 years after the first childbirth. J Ultrasound Med. 2018; 37:2829–2839. PMID: 29675869.

8. van Delft KW, Thakar R, Sultan AH, IntHout J, Kluivers KB. The natural history of levator avulsion one year following childbirth: a prospective study. BJOG. 2015; 122:1266–1273. PMID: 25514994.

9. van Delft K, Sultan AH, Thakar R, Schwertner-Tiepelmann N, Kluivers K. The relationship between postpartum levator ani muscle avulsion and signs and symptoms of pelvic floor dysfunction. BJOG. 2014; 121:1164–1171. PMID: 24548759.

10. National Institutes of Health (US). Zinc: fact sheet for health professionals. Bethesda (MD): National Institutes of Health;2020. cited 2019 Sep 28. Available from: https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/.

11. Takacs P, Jaramillo S, Zhang Y, Datar R, Williams A, Olczyk J, et al. The effects of PPARδ agonist and zinc on ovariectomized rats' vagina. Female Pelvic Med Reconstr Surg. 2013; 19:126–131. PMID: 23611928.

12. Takacs P, Zhang Y, Candiotti K, Jaramillo S, Medina CA. Effects of PPAR-delta agonist and zinc on vaginal smooth muscle cells collagen and tropoelastin production. Int Urogynecol J Pelvic Floor Dysfunct. 2012; 23:1775–1779.

13. Taneja SK, Kaur R. Pathology of ovary, uterus, vagina and gonadotrophs of female mice fed on Zn-deficient diet. Indian J Exp Biol. 1990; 28:1058–1065. PMID: 2283172.

14. Kelkar MA, Khar SK, Mandakhot VM. Studies on antepartum prolapse of the vagina in buffalo--plasma trace element concentrations. Arch Exp Veterinarmed. 1989; 43:315–318. PMID: 2774829.

15. Ozdemir S, Ozis ES, Gulpinar K, Aydin SM, Eren AA, Demirtas S, et al. The value of copper and zinc levels in hernia formation. Eur J Clin Invest. 2011; 41:285–290. PMID: 20955209.

16. Schulpis KH, Karakonstantakis T, Vlachos GD, Mentis AF, Karikas GA, Afordakou D, et al. Maternal-neonatal magnesium and zinc serum concentrations after vaginal delivery. Scand J Clin Lab Invest. 2010; 70:465–469. PMID: 20658899.

17. Lazebnik N, Kuhnert BR, Kuhnert PM, Thompson KL. Zinc status, pregnancy complications, and labor abnormalities. Am J Obstet Gynecol. 1988; 158:161–166. PMID: 3337165.

18. Caulfield LE, Zavaleta N, Shankar AH, Merialdi M. Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr. 1998; 68:499S–508S. PMID: 9701168.

19. Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr. 2015; 102:115–122. PMID: 25994567.

20. Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr. 2011; 93:402–412. PMID: 21159787.

21. Gingras AA, White PJ, Chouinard PY, Julien P, Davis TA, Dombrowski L, et al. Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J Physiol. 2007; 579:269–284. PMID: 17158167.

22. Di Girolamo FG, Situlin R, Mazzucco S, Valentini R, Toigo G, Biolo G. Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014; 17:145–150. PMID: 24500439.

23. Trabal J, Forga M, Leyes P, Torres F, Rubio J, Prieto E, et al. Effects of free leucine supplementation and resistance training on muscle strength and functional status in older adults: a randomized controlled trial. Clin Interv Aging. 2015; 10:713–723. PMID: 25926725.

24. Rowlands DS, Nelson AR, Phillips SM, Faulkner JA, Clarke J, Burd NA, et al. Protein-leucine fed dose effects on muscle protein synthesis after endurance exercise. Med Sci Sports Exerc. 2015; 47:547–555. PMID: 25026454.

25. Luiking YC, Deutz NE, Memelink RG, Verlaan S, Wolfe RR. Postprandial muscle protein synthesis is higher after a high whey protein, leucine-enriched supplement than after a dairy-like product in healthy older people: a randomized controlled trial. Nutr J. 2014; 13:9. PMID: 24450500.

26. Afshari P, Dabagh F, Iravani M, Abedi P. Comparison of pelvic floor muscle strength in nulliparous women and those with normal vaginal delivery and cesarean section. Int Urogynecol J Pelvic Floor Dysfunct. 2017; 28:1171–1175.

27. Myer EN, Roem JL, Lovejoy DA, Abernethy MG, Blomquist JL, Handa VL. Longitudinal changes in pelvic floor muscle strength among parous women. Am J Obstet Gynecol. 2018; 219:482.e1–482.e7. PMID: 29902445.

28. Dietz HP, Abbu A, Shek KL. The levator-urethra gap measurement: a more objective means of determining levator avulsion? Ultrasound Obstet Gynecol. 2008; 32:941–945. PMID: 19035543.

29. Dietz HP, Garnham AP, Rojas RG. Is the levator-urethra gap helpful for diagnosing avulsion? Int Urogynecol J Pelvic Floor Dysfunct. 2016; 27:909–913.

30. Kozma B, Larson K, Scott L, Cunningham TD, Abuhamad A, Poka R, et al. Association between pelvic organ prolapse types and levator-urethra gap as measured by 3D transperineal ultrasound. J Ultrasound Med. 2018; 37:2849–2854. PMID: 29672905.

31. Kamisan Atan I, Shek KL, Furtado GI, Caudwell-Hall J, Dietz HP. The association between levator-urethra gap measurements and symptoms and signs of female pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2016; 22:442–446. PMID: 27465815.

32. Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005; 193:103–113. PMID: 16021067.

33. Dietz HP, Simpson JM. Levator trauma is associated with pelvic organ prolapse. BJOG. 2008; 115:979–984. PMID: 18503571.

34. Pereira VS, Hirakawa HS, Oliveira AB, Driusso P. Relationship among vaginal palpation, vaginal squeeze pressure, electromyographic and ultrasonographic variables of female pelvic floor muscles. Braz J Phys Ther. 2014; 18:428–434. PMID: 25372005.

35. Nyhus MØ, Salvesen KÅ, Volløyhaug I. Association between pelvic floor muscle trauma and contraction in parous women from a general population. Ultrasound Obstet Gynecol. 2019; 53:262–268. PMID: 30084230.